United Therapeutics (UTHR) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
United Therapeutics Corporation  (NASDAQ: UTHR)

United Therapeutics Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

UTHR Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q1 MRQ) 82.93 % 70.91 % 67.38 % 46.15 %
Gross Margin (Q1 TTM) 86.58 % 71.7 % 67.8 % 46.36 %
Gross Profit Margin 5 Yr. Avg. 90.2 % 67.81 % 65.55 % 48.95 %
EBITDA Margin (Q1 MRQ) 43.62 % 21.48 % 18.44 % 20.46 %
EBITDA Margin (Q1 TTM) 53.54 % 25.18 % 20.78 % 20.1 %
EBITDA Margin 5 Yr. Avg. 52.97 % 47.09 % 31.38 % 23.41 %
Operating Margin (Q1 MRQ) 41.69 % 17.3 % 16.52 % 16.05 %
Operating Margin (Q1 TTM) 45.29 % 20.35 % 17.83 % 16.34 %
Operating Margin 5 Yr. Avg. 45.85 % 15.37 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q1 MRQ) 40.73 % 13.68 % 10.72 % 13.96 %
Pre-Tax Profit Margin (Q1 TTM) 50.75 % 16.7 % 12.68 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. 49.28 % 12.98 % 10.37 % 13.52 %
Net Margin (Q1 MRQ) 35.18 % 10.12 % 8.02 % 11.42 %
Net Margin (Q1 TTM) 40.61 % 13.16 % 9.86 % 10.76 %
Net Margin 5 Yr. Avg. 38.31 % 5.79 % 6.08 % 10.8 %



Business Segment Profit Margin
 
Tyvaso DPI
  Explore Tyvaso DPI Segment  74.81 %
Nebulized Tyvaso
  Explore Nebulized Tyvaso Segment  93.24 %
Remodulin
  Explore Remodulin Segment  87.28 %
Orenitram
  Explore Orenitram Segment  94.54 %
Unituxin
  Explore Unituxin Segment  90.67 %
Adcirca
  Explore Adcirca Segment  65.52 %
Other
  Explore Other Segment  -
Total Tyvaso
  Explore Total Tyvaso Segment  -
U S
  Explore U S Segment  -
U S Total Tyvaso
  Explore U S Total Tyvaso Segment  -
U S Tyvaso DPI
  Explore U S Tyvaso DPI Segment  -
U S Nebulized Tyvaso
  Explore U S Nebulized Tyvaso Segment  -
U S Remodulin
  Explore U S Remodulin Segment  -
U S Orenitram
  Explore U S Orenitram Segment  -
U S Unituxin
  Explore U S Unituxin Segment  -
U S Adcirca
  Explore U S Adcirca Segment  -
U S Other
  Explore U S Other Segment  -
ROW
  Explore ROW Segment  -
ROW Total Tyvaso
  Explore ROW Total Tyvaso Segment  -
ROW Nebulized Tyvaso
  Explore ROW Nebulized Tyvaso Segment  -
ROW Remodulin
  Explore ROW Remodulin Segment  -
ROW Unituxin
  Explore ROW Unituxin Segment  -
ROW Other
  Explore ROW Other Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q1 MRQ) 46.39 % -0.01 % 0.22 % 1.39 %
Free Cash Flow Margin (Q1 TTM) 31.91 % 17.26 % 13.83 % 9.09 %
Free Cash Flow Margin 5 Yr. Avg. - 19.28 % 14.86 % 15.58 %
Net Cash Flow Margin (Q1 MRQ) -35.5 % 0.02 % -0.02 % 0.13 %
Net Cash Flow Margin (Q1 TTM) -19.57 % -0.67 % 0.15 % 1.85 %
Net Cash Flow Margin 5 Yr. Avg. - 4.38 % 3.16 % 6.44 %
Effective Tax Rate (Q1 MRQ) 13.63 % 25.92 % 25.04 % 18.8 %
Effective Tax Rate (Q1 TTM) 19.97 % 21.21 % 23 % 19.44 %
Effective Tax Rate 5 Yr. Avg. 22.11 % 15.08 % 20.51 % 19.76 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.